A Randomized, Double-Blind Comparison of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil fumarate (TDF), Each Coformulated with Elvitegravir, Cobicistat, and Emtricitabine...

Arribas, José R.; Thompson, Melanie; Sax, Paul E.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes ., Post Acceptance: March 09, 2017

A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults

Huhn, Gregory D.; Tebas, Pablo; Gallant, Joel; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 74(2):193-200, February 1, 2017.

Brief Report: A Randomized, Double-Blind Comparison of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate, Each Coformulated With Elvitegravir, Cobicistat, and...

Wohl, David; Oka, Shinichi; Clumeck, Nathan; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 72(1):58-64, May 1, 2016.

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor–Based Single-Tablet Regimen for Initial HIV-1 Therapy: A Randomized Phase 2 Study

Mills, Anthony; Crofoot, Gordon Jr; McDonald, Cheryl; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 69(4):439-445, August 1, 2015.

Tenofovir Alafenamide Vs. Tenofovir Disoproxil Fumarate in Single Tablet Regimens for Initial HIV-1 Therapy: A Randomized Phase 2 Study

Sax, Paul E.; Zolopa, Andrew; Brar, Indira; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 67(1):52-58, September 1, 2014.

Antiviral Activity, Safety, and Pharmacokinetics/Pharmacodynamics of Tenofovir Alafenamide as 10-Day Monotherapy in HIV-1–Positive Adults

Ruane, Peter J.; DeJesus, Edwin; Berger, Daniel; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 63(4):449-455, August 1, 2013.